NEW DELHI: Sun Pharmaceutical Industries Ltd, India’s largest drugmaker, said its US unit received a grand jury subpoena from the US Department of Justice’s antitrust division related to generic products and pricing.
The summons also sought documents about communications with competitors and others regarding the sale of generic drugs, along with corporate and employee records, Sun Pharma said in a stock exchange filing on Friday.
There has been public outcry in the US and congressional scrutiny over price increases for prescription drugs, including many older, off-patent medications, that are putting them out of reach for many patients. At a Senate hearing in March, Senator Claire McCaskill, a Democrat, called jacking up drug prices a “sick game” in announcing a bipartisan investigation into pharmaceutical drug pricing.
